These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 28509725)

  • 41. Efficacy and safety of olmesartan medoxomil and hydrochlorothiazide compared with benazepril and amlodipine besylate.
    Kereiakes DJ; Neutel JM; Punzi HA; Xu J; Lipka LJ; Dubiel R
    Am J Cardiovasc Drugs; 2007; 7(5):361-72. PubMed ID: 17953475
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
    Pool JL; Glazer R; Weinberger M; Alvarado R; Huang J; Graff A
    Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An update on telmisartan/hydrochlorothiazide combinations for the management of hypertensive patients with additional cardiovascular risk factors.
    Kjeldsen S; Mancia G; Schmieder R; Mattheus M; Unger T
    Expert Rev Cardiovasc Ther; 2013 Jun; 11(6):673-82. PubMed ID: 23750676
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term effect of nifedipine and hydrochlorothiazide on blood pressure and sodium homeostasis at varying levels of salt intake in mildly hypertensive patients.
    Luft FC; Fineberg NS; Weinberger MH
    Am J Hypertens; 1991 Sep; 4(9):752-60. PubMed ID: 1930859
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of salt supplementation on the albuminuric response to telmisartan with or without hydrochlorothiazide therapy in hypertensive patients with type 2 diabetes are modulated by habitual dietary salt intake.
    Ekinci EI; Thomas G; Thomas D; Johnson C; Macisaac RJ; Houlihan CA; Finch S; Panagiotopoulos S; O'Callaghan C; Jerums G
    Diabetes Care; 2009 Aug; 32(8):1398-403. PubMed ID: 19549737
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of triple combination therapy with azilsartan/amlodipine/hydrochlorothiazide on office/home blood pressure: a randomized-controlled trial in Japanese essential hypertensive patients.
    Rakugi H; Shimizu K; Sano Y; Nishiyama Y; Kinugawa Y; Terashio S
    Blood Press Monit; 2018 Apr; 23(2):91-102. PubMed ID: 29239867
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Telmisartan/Hydrochlorothiazide in comparison with losartan/hydrochlorothiazide in managing patients with mild-to-moderate hypertension.
    Neutel JM; Littlejohn TW; Chrysant SG; Singh A;
    Hypertens Res; 2005 Jul; 28(7):555-63. PubMed ID: 16335883
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comparative study on the effectiveness of losartan/hydrochlorothiazide and telmisartan/hydrochlorothiazide in patients with hypertension.
    Hamada T; Kuwabara M; Watanabe A; Mizuta E; Ohtahara A; Omodani H; Watanabe M; Nakamura H; Hirota Y; Miyazaki S; Kato M; Ogino K; Kosaka H; Haruaki N; Taniguchi S; Yamamoto K; Kotake H; Hisatome I
    Clin Exp Hypertens; 2014; 36(4):251-7. PubMed ID: 23865441
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Telmisartan: a review of its use in the management of hypertension.
    Battershill AJ; Scott LJ
    Drugs; 2006; 66(1):51-83. PubMed ID: 16398568
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Telmisartan in combination with hydrochlorothiazide 12.5 mg for the management of patients with hypertension.
    Neldam S; Schumacher H; Kjeldsen SE; Neutel JM
    Curr Med Res Opin; 2014 Sep; 30(9):1715-24. PubMed ID: 24834808
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effectiveness of hydrochlorothiazide in combination with telmisartan and olmesartan in adults with moderate hypertension not controlled with monotherapy: a prospective, randomized, open-label, blinded end point (PROBE), parallel-arm study.
    Fogari R; Zoppi A; Mugellini A; Preti P; Destro M; Rinaldi A; Derosa G
    Curr Ther Res Clin Exp; 2008 Feb; 69(1):1-15. PubMed ID: 24692778
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and effects on lipid metabolism of combination treatment with losartan + hydrochlorothiazide versus losartan + amlodipine: a 48-week prospective, multicenter, randomized, open-label trial.
    Nishiwaki M; Hosoai H; Ikewaki K; Ayaori M; Yamashita T; Shige H; Higashi K; Nashida Y; Shimizu S; Kijima F; Yokoyama M; Nakamura H;
    Clin Ther; 2013 Apr; 35(4):461-73. PubMed ID: 23490288
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sustained decrease in blood pressure following missed doses of aliskiren or telmisartan: the ASSERTIVE double-blind, randomized study.
    Düsing R; Brunel P; Baek I; Baschiera F
    J Hypertens; 2012 May; 30(5):1029-40. PubMed ID: 22441345
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of the effects of barnidipine+losartan compared with telmisartan+hydrochlorothiazide on several parameters of insulin sensitivity in patients with hypertension and type 2 diabetes mellitus.
    Derosa G; Querci F; Franzetti I; Dario Ragonesi P; D'Angelo A; Maffioli P
    Hypertens Res; 2015 Oct; 38(10):690-4. PubMed ID: 25994603
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The safety profile of telmisartan as monotherapy or combined with hydrochlorothiazide: a retrospective analysis of 50 studies.
    Schumacher H; Mancia G
    Blood Press Suppl; 2008 Jun; 1():32-40. PubMed ID: 18705533
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Candesartan cilexetil plus hydrochlorothiazide combination: a review of its use in hypertension.
    Melian EB; Jarvis B
    Drugs; 2002; 62(5):787-816. PubMed ID: 11929332
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of fimasartan/hydrochlorothiazide combination in hypertensive patients inadequately controlled by fimasartan monotherapy.
    Rhee MY; Baek SH; Kim W; Park CG; Park SW; Oh BH; Kim SH; Kim JJ; Shin JH; Yoo BS; Rim SJ; Ha JW; Doh JH; Ahn Y; Chae JK; Park JB; Kim SK; Kim CH
    Drug Des Devel Ther; 2015; 9():2847-54. PubMed ID: 26082615
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Single-pill combination of telmisartan/amlodipine versus amlodipine monotherapy in diabetic hypertensive patients: an 8-week randomized, parallel-group, double-blind trial.
    Sharma AM; Bakris G; Neutel JM; Littlejohn TW; Kobe M; Ting N; Ley L
    Clin Ther; 2012 Mar; 34(3):537-51. PubMed ID: 22386829
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is the fixed-dose combination of telmisartan and hydrochlorothiazide a good approach to treat hypertension?
    Maillard MP; Burnier M
    Vasc Health Risk Manag; 2007; 3(3):265-78. PubMed ID: 17703634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.